Details for New Drug Application (NDA): 200290
✉ Email this page to a colleague
The generic ingredient in LOSARTAN POTASSIUM is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 200290
Tradename: | LOSARTAN POTASSIUM |
Applicant: | Ipca Labs Ltd |
Ingredient: | losartan potassium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 200290
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Aug 30, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Aug 30, 2013 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Aug 30, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription